CYPH (Cypherpunk Technologies) Research & Development: $12.92 Mil (TTM As of Mar. 2026)


CYPH Cypherpunk Technologies Inc CYPH
28 GF Score
Price $0.63
! 3 Warning Signs
View Full Analysis

What is Cypherpunk Technologies Research & Development?

Cypherpunk Technologies CYPH +3.34% 28 Research & Development is $12.92 Mil as of Mar. 2026. GuruFocus rates CYPH with a GF Score™ of 28/100. The stock has 3 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Cypherpunk Technologies's Research & Development for the three months ended in Mar. 2026 was $0.16 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was $12.92 Mil.

Cypherpunk Technologies  (NAS:CYPH) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Cypherpunk Technologies Research & Development Related Terms

Cypherpunk Technologies Research & Development Historical Data

* Premium members only.

The historical data trend for Cypherpunk Technologies's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cypherpunk Technologies Research & Development Chart

Cypherpunk Technologies Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 32.16 44.97 73.23 57.21 25.67

Cypherpunk Technologies Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.91 10.54 1.25 0.98 0.16
CYPH
28GF Score
Cypherpunk Technologies Inc CYPH
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cypherpunk Technologies Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $12.92 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $12.92 Mil mean?
Cypherpunk Technologies (CYPH) has a Research & Development of $12.92 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Cypherpunk Technologies and its competitors.
Is Cypherpunk Technologies' Research & Development too high?
Cypherpunk Technologies' current Research & Development is $12.92 Mil. Overall, Cypherpunk Technologies has a GF Score™ of 28/100, reflecting its overall financial health beyond just this single metric.
How does Cypherpunk Technologies' Research & Development compare to PFO and NMI?
Cypherpunk Technologies' Research & Development of $12.92 Mil can be compared against companies in the Asset Management industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for an Asset Management company?
A good Research & Development depends on the Asset Management industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Cypherpunk Technologies and its competitors. Cypherpunk Technologies's current Research & Development is $12.92 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cypherpunk Technologies stock overvalued right now?
Cypherpunk Technologies (CYPH) has a current Research & Development of $12.92 Mil. The current Research & Development is $12.92 Mil. Cypherpunk Technologies' overall GF Score™ is 28/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Cypherpunk Technologies (CYPH), the current Research & Development is $12.92 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cypherpunk Technologies Business Description

Other Exchanges 5MC:Germany
Address 47 Thorndike Street, Suite B1-1, Cambridge, MA, USA, 02141
Cypherpunk Technologies Inc is a privacy technology company focused on implementing a digital asset treasury business anchored by Zcash, which is a cryptographic digital asset that operates on a decentralized, open-source blockchain network known as the Zcash Network. Through its subsidiary, the company is also engaged in developing novel therapies for patients with cancer. The group holds Zcash as part of its digital treasury business and has the following drug candidates under development in its biopharma business: Sirexatamab (DKN-01), a monoclonal antibody that inhibits Dickkopf-related protein 1, or DKK1; and a preclinical antibody program, FL-501, that is designed to treat cachexia-related indications.
28GF Score

Get the complete analysis for CYPH

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.63
Price